Perceptive Advisors - ALBIREO PHARMA INC ownership

ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 5 filers reported holding ALBIREO PHARMA INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of ALBIREO PHARMA INC
ValueSharesWeighting
Q4 2022$37,972,228
-16.9%
1,757,160
-25.5%
1.07%
-19.6%
Q3 2022$45,692,000
-2.5%
2,360,1390.0%1.33%
-9.7%
Q2 2022$46,872,000
-33.4%
2,360,1390.0%1.47%
+4.1%
Q1 2022$70,403,000
-36.0%
2,360,139
-50.0%
1.41%
+66.3%
Q4 2021$109,936,000
+49.3%
4,720,278
+100.0%
0.85%
-20.7%
Q3 2021$73,636,000
-55.7%
2,360,139
-50.0%
1.07%
-0.8%
Q2 2021$166,060,000
+99.6%
4,720,278
+100.0%
1.08%
+2.6%
Q1 2021$83,195,000
-6.0%
2,360,1390.0%1.05%
+10.7%
Q4 2020$88,529,000
+12.4%
2,360,1390.0%0.95%
-17.4%
Q3 2020$78,758,000
+51.7%
2,360,139
+20.4%
1.15%
+36.7%
Q2 2020$51,924,000
+62.6%
1,960,1390.0%0.84%
+1.1%
Q1 2020$31,931,000
-26.3%
1,960,139
+15.0%
0.83%
-3.4%
Q4 2019$43,324,000
+27.1%
1,704,3300.0%0.86%
-6.2%
Q3 2019$34,087,000
-38.0%
1,704,3300.0%0.92%
-27.2%
Q2 2019$54,948,000
+0.1%
1,704,3300.0%1.26%
-18.6%
Q1 2019$54,896,000
+39.0%
1,704,3300.0%1.55%
+3.0%
Q4 2018$39,506,000
-29.7%
1,704,3300.0%1.50%
+0.1%
Q3 2018$56,175,000
-7.2%
1,704,3300.0%1.50%
-5.3%
Q2 2018$60,504,000
+9.0%
1,704,3300.0%1.59%
+2.0%
Q1 2018$55,510,000
+64.3%
1,704,330
+29.1%
1.56%
+38.8%
Q4 2017$33,792,000
-4.6%
1,320,000
-21.9%
1.12%
+65.7%
Q3 2017$35,406,000
+103.4%
1,690,000
+100.0%
0.68%
-22.8%
Q2 2017$17,407,000845,0000.88%
Other shareholders
ALBIREO PHARMA INC shareholders Q1 2023
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 1$7440.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ALBIREO PHARMA INC shareholders